Citations (45)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Hafez Ibrahim, Salem Al Qurashi, Mubarak Abdullah, Ali Hajeer, Khaled O. Alsaad & Abdulla Al Sayyari. (2016) Antibody-mediated rejection and aHUS in renal graft recipient. Cogent Medicine 3:1.
Read now
Read now
Articles from other publishers (44)
Christina L. Tamargo & Sam Kant. (2023) Pathophysiology of Rejection in Kidney Transplantation. Journal of Clinical Medicine 12:12, pages 4130.
Crossref
Crossref
Xin Li, Ruoying Li, Bingqing Ji, Lili Zhao, Junpeng Wang & Tianzhong Yan. (2022) Integrative metagenomic and metabolomic analyses reveal the role of gut microbiota in antibody-mediated renal allograft rejection. Journal of Translational Medicine 20:1.
Crossref
Crossref
Somaye-Sadat Heidari, Mohsen Nafar, Shiva Kalantari, Heidar Tavilani, Jamshid Karimi, Leonard Foster, Kyung-Mee Moon & Iraj Khodadadi. (2021) Urinary epidermal growth factor is a novel biomarker for early diagnosis of antibody mediated kidney allograft rejection: A urinary proteomics analysis. Journal of Proteomics 240, pages 104208.
Crossref
Crossref
Junpeng Wang, Xin Li, Xiaoqiang Wu, Zhiwei Wang, Chan Zhang, Guanghui Cao, Shun Liu & Tianzhong Yan. (2021) Gut microbiota alterations associated with antibody-mediated rejection after kidney transplantation. Applied Microbiology and Biotechnology 105:6, pages 2473-2484.
Crossref
Crossref
Suman Krishna Kotla & Bekir Tanriover. (2020) Recurrent antibody-mediated rejection in renal allograft: physician’s dilemma. Journal of Nephrology 33:4, pages 661-665.
Crossref
Crossref
J. Bahena Méndez, L.R. López y López, M.A. Sebastián Díaz, I. Trejo Curiel, R. Galindo-Lopéz, A. Baca Córdova, M. Wasung de Lay, R.A. Vázquez Dávila, P.A. Zarate Rodríguez & M.A. Carmona-Escamilla. (2020) Antibody-Mediated Rejection Treatment With Bortezomib in Renal Transplant Recipients: A Single-Center 24-Month Follow-up Case Report. Transplantation Proceedings 52:4, pages 1123-1126.
Crossref
Crossref
Johanna Egelkamp, Evgeny Chichelnitskiy, Jenny F. Kühne, Franziska Wandrer, Kerstin Daemen, Jana Keil, Jan Hinrich Bräsen, Jessica Schmitz, Ramon Bellmàs-Sanz, Susanne Iordanidis, Katherina Katsirntaki, Kevin Hake, Ali Akhdar, Christine Neudörfl, Hermann Haller, Cornelia Blume & Christine S. Falk. (2019) Back signaling of HLA class I molecules and T/NK cell receptor ligands in epithelial cells reflects the rejection-specific microenvironment in renal allograft biopsies. American Journal of Transplantation 19:10, pages 2692-2704.
Crossref
Crossref
Tobias Fretwurst, Lames M. Gad, Thorsten Steinberg, Hagen Schmal, Robert Zeiser, Anna-K. Amler, Katja Nelson & Brigitte Altmann. (2018) Detection of major histocompatibility complex molecules in processed allogeneic bone blocks for use in alveolar ridge reconstruction. Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology 126:1, pages 16-21.
Crossref
Crossref
Xicohténcatl Ixtlapale-Carmona, Adriana Arvizu, Adrian De-Santiago, Norma González-Tableros, Mayra López, Natalia Castelán, Lluvia A. Marino, Norma O. Uribe-Uribe, Alan G. Contreras, Mario Vilatobá, Luis E. Morales-Buenrostro & Josefina Alberú. (2018) Graft immunologic events in deceased donor kidney transplant recipients with preformed HLA-donor specific antibodies. Transplant Immunology 46, pages 8-13.
Crossref
Crossref
Jingli Lu & Xiaojian Zhang. (2016) Immunological characteristics of renal transplant tolerance in humans. Molecular Immunology 77, pages 71-78.
Crossref
Crossref
Johann Castañeda-Sanabria, David Hajage, Melisande Le Jouan, Anne Perozziello & Florence Tubach. (2016) Off-label use of the expensive orphan drug eculizumab in France 2009–2013 and the impact of literature: focus on the transplantation field. European Journal of Clinical Pharmacology 72:6, pages 737-746.
Crossref
Crossref
S. Mehrotra, R.K. Sharma, N. Prasad, A. Gupta, D.S. Bhadauria, A. Kaul, M. Jain & P. Rishishwar. (2016) The importance of donor-specific anti-HLA antibodies (DSA) identification in renal transplant patients with C4d-negative biopsies. Indian Journal of Transplantation 10:1, pages 15-21.
Crossref
Crossref
M. Cataldi & A. Cavaccini. 2016. Reference Module in Biomedical Sciences. Reference Module in Biomedical Sciences.
H. Suhling, J. Gottlieb, C. Bara, R. Taubert, E. Jäckel, M. Schiffer & J.H. Bräsen. (2016) Chronische AbstoßungChronic rejection. Der Internist 57:1, pages 25-37.
Crossref
Crossref
Oriol Bestard & Minnie M. Sarwal. (2014) Antibody-mediated rejection in young kidney transplant recipients: the dilemma of noncompliance and insufficient immunosuppression. Pediatric Nephrology 30:3, pages 397-403.
Crossref
Crossref
Luis Landin, Pedro Bolado & Cesar Casado-Sanchez. 2015. The Science of Reconstructive Transplantation. The Science of Reconstructive Transplantation
145
162
.
Nicole S. EjazRita R. AllowayFabian HalleckMichael DürrKlemens BuddeE. Steve Woodle. (2014) Review of Bortezomib Treatment of Antibody-Mediated Rejection in Renal Transplantation. Antioxidants & Redox Signaling 21:17, pages 2401-2418.
Crossref
Crossref
Maren Burbach, Caroline Suberbielle, Isabelle Brochériou, Christophe Ridel, Laurent Mesnard, Karine Dahan, Eric Rondeau & Alexandre Hertig. (2014) Report of the Inefficacy of Eculizumab in Two Cases of Severe Antibody-Mediated Rejection of Renal Grafts. Transplantation 98:10, pages 1056-1059.
Crossref
Crossref
Miae Kim, Spencer T. Martin, Keri R. Townsend & Steven Gabardi. (2014)
Antibody-Mediated Rejection in Kidney Transplantation: A Review of Pathophysiology, Diagnosis, and Treatment Options
. Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 34:7, pages 733-744.
Crossref
Crossref
Gaurav Gupta, Bassam G. Abu Jawdeh, Lorraine C. Racusen, Bhavna Bhasin, Lois J. Arend, Brandon Trollinger, Edward Kraus, Hamid Rabb, Andrea A. Zachary, Robert A. Montgomery & Nada Alachkar. (2014) Late Antibody-Mediated Rejection in Renal Allografts. Transplantation 97:12, pages 1240-1246.
Crossref
Crossref
L. Longshan, L. Dongwei, F. Qian, L. Jun, D. Suxiong, Z. Yitao, X. Yunyi, H. Huiting, C. Lizhong, F. Jiguang & W. Changxi. (2014) Dynamic Analysis of B-Cell Subsets in De Novo Living Related Kidney Transplantation With Induction Therapy of Basiliximab. Transplantation Proceedings 46:2, pages 363-367.
Crossref
Crossref
A. Djamali, D.B. Kaufman, T.M. Ellis, W. Zhong, A. Matas & M. Samaniego. (2014) Diagnosis and Management of Antibody-Mediated Rejection: Current Status and Novel Approaches. American Journal of Transplantation 14:2, pages 255-271.
Crossref
Crossref
Basma Sadaka, Rita R. Alloway & E. Steve Woodle. (2013) Management of Antibody-Mediated Rejection in Transplantation. Surgical Clinics of North America 93:6, pages 1451-1466.
Crossref
Crossref
Katherine Twombley, Lonnie Thach, Annelise Ribeiro, Catherine Joseph & Mouin Seikaly. (2013) Acute antibody-mediated rejection in pediatric kidney transplants: A single center experience. Pediatric Transplantation, pages n/a-n/a.
Crossref
Crossref
S. Westphal, S. Hansson, G. Stelin, J. Holgersson, L. Mjörnstedt & S. Friman. (2013) Successful Treatment of Severe ABO Antibody-Mediated Rejection Using Bortezomib: A Case Report. Transplantation Proceedings 45:3, pages 1213-1215.
Crossref
Crossref
Kwan-Tae Park, Cheol-Woong Jung & Myung-Gyu Kim. (2013) Update on the Treatment of Acute and Chronic Antibody-mediated Rejection. Korean Journal of Transplantation 27:1, pages 6-14.
Crossref
Crossref
Rosana Rosa Miranda Corrêa, Juliana Reis Machado, Marcos Vinícius da Silva, Fernanda Rodrigues Helmo, Camila Souza Oliveira Guimarães, Laura Penna Rocha, Ana Carolina Guimarães Faleiros & Marlene Antônia dos Reis. (2013) The Importance of C4d in Biopsies of Kidney Transplant Recipients. Clinical and Developmental Immunology 2013, pages 1-8.
Crossref
Crossref
Janice G. Nigos, Swati Arora, Parineesha Nath, Sabiha M. Hussain, Richard J. Marcus, Tina Y. Ko & Kalathil K. Sureshkumar. (2012) Treatment of Antibody-Mediated Rejection in Kidney Transplant Recipients: A Single-Center Experience With a Bortezomib-Based Regimen. Experimental and Clinical Transplantation 10:6, pages 609-613.
Crossref
Crossref
Henrik Ekberg & Martin E. Johansson. (2012) Challenges and considerations in diagnosing the kidney disease in deteriorating graft function. Transplant International 25:11, pages 1119-1128.
Crossref
Crossref
F. González-Roncero, M. Suñer, G. Bernal, V. Cabello, M. Toro, P. Pereira & M. Angel Gentil. (2012) Eculizumab Treatment of Acute Antibody-Mediated Rejection in Renal Transplantation: Case Reports. Transplantation Proceedings 44:9, pages 2690-2694.
Crossref
Crossref
Mareen Matz, Martin Lehnert, Christine Lorkowski, Katharina Fabritius, Nadine Unterwalder, Salim Doueiri, Ulrike A. Weber, Mir-Farzin Mashreghi, Hans-H. Neumayer & Klemens Budde. (2012) Effects of sotrastaurin, mycophenolic acid and everolimus on human B-lymphocyte function and activation. Transplant International 25:10, pages 1106-1116.
Crossref
Crossref
D. Noone, J. Al-Matrafi, K. Tinckam, P.F. Zipfel, A.M. Herzenberg, P.S. Thorner, F.G. Pluthero, W.H.A. Kahr, G. Filler, D. Hebert, E. Harvey & C. Licht. (2012) Antibody Mediated Rejection Associated With Complement Factor H–Related Protein 3/1 Deficiency Successfully Treated With Eculizumab. American Journal of Transplantation 12:9, pages 2546-2553.
Crossref
Crossref
Alexandra Joseph, Kathleen Neff, Julie Richard, Lan Gao, Dinesh Bangari, Marguerite Joly, Kerry Culm-Merdek, Richard Garman, John Williams, Susan Richards & Melanie Ruzek. (2012) Transient Low-Dose Methotrexate Induces Tolerance to Murine Anti-Thymocyte Globulin and Together They Promote Long-Term Allograft Survival. The Journal of Immunology 189:2, pages 732-743.
Crossref
Crossref
A. Sicard, T.W. Phares, H. Yu, R. Fan, W.M. BaldwinIIIIII, R.L. Fairchild & A. Valujskikh. (2012) The Spleen Is the Major Source of Antidonor Antibody-Secreting Cells in Murine Heart Allograft Recipients. American Journal of Transplantation 12:7, pages 1708-1719.
Crossref
Crossref
Basma Sadaka, Rita R. Alloway, Adele R. Shields, Nicole M. Schmidt & E. Steve Woodle. (2012) Proteasome Inhibition for Antibody-Mediated Allograft Rejection. Seminars in Hematology 49:3, pages 263-269.
Crossref
Crossref
Danielle Cohen, Robert B. Colvin, Mohamed R. Daha, Cinthia B. Drachenberg, Mark Haas, Volker Nickeleit, Jane E. Salmon, Banu Sis, Ming-Hui Zhao, Jan A. Bruijn & Ingeborg M. Bajema. (2012) Pros and cons for C4d as a biomarker. Kidney International 81:7, pages 628-639.
Crossref
Crossref
Matthew H. Levine & Peter L. Abt. (2012) Treatment options and strategies for antibody mediated rejection after renal transplantation. Seminars in Immunology 24:2, pages 136-142.
Crossref
Crossref
Hari Varun Kalluri. (2012) Current state of renal transplant immunosuppression: Present and future. World Journal of Transplantation 2:4, pages 51.
Crossref
Crossref
Olivia R. Blume, Sarah E. Yost & Bruce Kaplan. (2012) Antibody-Mediated Rejection: Pathogenesis, Prevention, Treatment, and Outcomes. Journal of Transplantation 2012, pages 1-7.
Crossref
Crossref
Tahmeena Ahmed & Lisa Senzel. (2012) The role of therapeutic apheresis in the treatment of acute antibody‐mediated kidney rejection. Journal of Clinical Apheresis 27:4, pages 173-177.
Crossref
Crossref
Vijay S. Gorantla & Anthony J. Demetris. (2011) Acute and Chronic Rejection in Upper Extremity Transplantation: What Have We Learned?. Hand Clinics 27:4, pages 481-493.
Crossref
Crossref
Sudeendra S Gupta & RK Sharma. (2011) Management of steroid-resistant acute rejection in renal transplantation. Indian Journal of Transplantation 5:4, pages 195-199.
Crossref
Crossref
Gerard Espinosa, Horacio Berman & Ricard Cervera. (2011) Management of refractory cases of catastrophic antiphospholipid syndrome. Autoimmunity Reviews 10:11, pages 664-668.
Crossref
Crossref
Shoba Amarnath, Hao Chen, Jason E. Foley, Carliann M. Costanzo, Joel D. Sennesh, Michael A. Solomon & Daniel H. Fowler. (2011) Host-Based Th2 Cell Therapy for Prolongation of Cardiac Allograft Viability. PLoS ONE 6:4, pages e18885.
Crossref
Crossref